Marsh & McLennan MRSH
Marsh & McLennan is a global insurance broker and risk consultant, intermediating between corporate clients and insurers for commissions, with a diversified network worldwide. Marsh & McLennan shows excellent financial health (ROE 25.9%, operating margin 26.3%) and stable growth (revenue +6.2%), but its valuation (P/E 20.87) already discounts these strengths, leaving little room for re-rating.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Marsh & McLennan is a global insurance broker and risk consultant, intermediating between corporate clients and insurers for commissions, with a diversified network worldwide. Marsh & McLennan shows excellent financial health (ROE 25.9%, operating margin 26.3%) and stable growth (revenue +6.2%), but its valuation (P/E 20.87) already discounts these strengths, leaving little room for re-rating.
Score by category
| Category | Score |
|---|---|
| Financial health | 8.8 |
| Quality / Moat | 7.2 |
| Valuation | 2.8 |
| Growth | 5.9 |
| Dividend | 6.9 |
| Momentum | 4.9 |
| Risk & Context | 8.2 |
OVERALL SCORE: 6.5/10
Context and risks
No additional regulatory, geopolitical, or business model risk requiring adjustment. The country governance risk (US) is already reflected in the base score.
News considered in the analysis
- Marsh CEO John Doyle on Navigating Global Risk, Cyber Threats and AI — Entrevista de perfil general sin información nueva material sobre resultados o valoración.
- Marsh CEO on How AI Will Fast-Track Early Careers — Comentario estratégico sobre talento, sin impacto cuantificable a corto plazo.
- 2 Cash-Producing Stocks with Promising Prospects and 1 That Underwhelm — Listículo genérico sin información específica accionable.
- Can Marsh Benefit From Changing Asset Owner Priorities? — Análisis de Zacks que sugiere demanda estructural por servicios de asesoría, pero es especulativo y sin cifras concretas.
- 3 Insurance Stocks Retail Investors Are Watching As War Risk Costs Rise — El aumento de primas por riesgo de guerra (Ormuz) puede elevar las comisiones de corretaje de Marsh, un efecto positivo moderado y ya parcialmente descontado.
Verdict: Hold: superior quality and profitability, but fair valuation and moderate growth; wait for a better entry point or a clear catalyst.
Main risk: The main risk is a global economic slowdown that reduces M&A activity and insurance purchasing, impacting Marsh's commission growth.
Other Financial Services companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →